Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$52.16 - $64.19 $5.17 Million - $6.36 Million
-99,158 Reduced 46.87%
112,417 $7.06 Million
Q3 2023

Nov 14, 2023

BUY
$57.77 - $65.93 $10.5 Million - $12 Million
181,601 Added 605.86%
211,575 $12.2 Million
Q2 2023

Aug 14, 2023

SELL
$60.95 - $75.51 $7.55 Million - $9.36 Million
-123,899 Reduced 80.52%
29,974 $1.87 Million
Q1 2023

May 15, 2023

BUY
$70.23 - $86.01 $10.8 Million - $13.2 Million
153,873 New
153,873 $11.1 Million
Q2 2022

Aug 15, 2022

SELL
$66.18 - $83.18 $30.9 Million - $38.9 Million
-467,644 Reduced 58.32%
334,180 $25.4 Million
Q1 2022

May 13, 2022

BUY
$66.02 - $79.71 $2.46 Million - $2.97 Million
37,244 Added 4.87%
801,824 $63.7 Million
Q4 2021

Feb 14, 2022

BUY
$63.34 - $74.11 $615,094 - $719,682
9,711 Added 1.29%
764,580 $56.1 Million
Q3 2021

Nov 12, 2021

BUY
$68.67 - $84.02 $37.9 Million - $46.3 Million
551,469 Added 271.13%
754,869 $51.9 Million
Q2 2021

Aug 13, 2021

BUY
$79.87 - $87.53 $16.2 Million - $17.8 Million
203,400 New
203,400 $17.1 Million
Q4 2020

Feb 12, 2021

SELL
$80.74 - $97.7 $4.21 Million - $5.1 Million
-52,200 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$85.07 - $109.69 $4.44 Million - $5.73 Million
52,200 New
52,200 $4.68 Million
Q2 2020

Aug 12, 2020

SELL
$74.18 - $108.93 $24.7 Million - $36.2 Million
-332,780 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$63.18 - $85.97 $239,578 - $325,998
-3,792 Reduced 1.13%
332,780 $24.4 Million
Q4 2019

Feb 13, 2020

BUY
$73.04 - $95.72 $11.1 Million - $14.5 Million
151,372 Added 81.73%
336,572 $29.4 Million
Q3 2019

Nov 14, 2019

BUY
$72.82 - $86.52 $12.8 Million - $15.2 Million
175,488 Added 1806.92%
185,200 $13.7 Million
Q2 2019

Aug 14, 2019

BUY
$73.52 - $88.7 $714,026 - $861,454
9,712 New
9,712 $825,000
Q4 2017

Feb 09, 2018

SELL
$93.56 - $116.6 $15.7 Million - $19.5 Million
-167,400 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$109.15 - $138.27 $18.3 Million - $23.1 Million
167,400
167,400 $19.5 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Arrowstreet Capital, Limited Partnership Portfolio

Follow Arrowstreet Capital, Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.